Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Metabolic Brain Disease|November 3, 2022
The role of brain inflammation and abnormal brain oxygen homeostasis in the development of hepatic encephalopathyAnne Catrine Daugaard Mikkelsen, Karen Louise Thomsen, Rajeshwar Prosad Mookerjee, et al.Metabolic Brain Disease|November 3, 2022
Hypokalaemia - an active contributor to hepatic encephalopathy?Anne Catrine Daugaard Mikkelsen, Karen Louise Thomsen, Hendrik Vilstrup, et al.Ugeskrift for Laeger|February 13, 2026
[Metabolic dysfunction-associated steatotic liver disease may affect the brain]Anne Catrine Daugaard Mikkelsen, Kristoffer Kjærgaard Amby, Mette Munk Lauridsen, et al.The Lancet. Gastroenterology & Hepatology|December 19, 2024
The liver-brain axis in metabolic dysfunction-associated steatotic liver diseaseAnne Catrine Daugaard Mikkelsen, Kristoffer Kjærgaard, Anthony H V Schapira, et al.Neurochemical Research|March 1, 2022
Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical EvidenceAnne Catrine Daugaard Mikkelsen, Kristoffer Kjærgaard, Rajeshwar Prosad Mookerjee, et al.Metabolic Brain Disease|February 1, 2022
Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy -current validation level and practical useMads Kingo Guldberg Hansen, Kristoffer Kjærgaard, Lotte Lindgreen Eriksen, et al.Journal of Clinical Medicine|February 12, 2021
Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and PerspectivesKristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Charlotte Wilhelmina Wernberg, et al.JHEP Reports : Innovation in Hepatology|December 16, 2025
Binge drinking acutely induces hepatic steatosis which is readily reversible: A real-world observational study in healthy adultsKristoffer Kjærgaard, Jeppe Mygind Yeoman, Peter Lykke Eriksen, et al.JHEP Reports : Innovation in Hepatology|February 28, 2024
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammationKristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Anne M Landau, et al.JHEP Reports : Innovation in Hepatology|June 9, 2026
Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver diseaseKaren Louise Thomsen, Vikram Sharma, Helen Jones, et al.Pageof 1